Clinical Trial Update: Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography [NA]

View source ↗

Summary

A clinical trial investigating the renal protective effect of pentoxifylline in high-risk patients undergoing angiography has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy
• Diabetes Mellitus

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Meir Medical Center | Conditions: Contrast Induced Nephropathy, Diabetes Mellitus | NA | Status: WITHDRAWN